Jolyon Fairburn-Beech
Overview
Explore the profile of Jolyon Fairburn-Beech including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
8
Citations
131
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Gungabissoon U, Smith H, von Maltzahn R, Logie J, Fairburn-Beech J, Ma L, et al.
BMJ Open Gastroenterol
. 2024 Mar;
11(1).
PMID: 38538090
Objective: Cholestatic pruritus in primary biliary cholangitis (PBC) reduces patients' health-related quality of life (HRQoL). Despite this, existing research suggests that pruritus is under-recorded in patients' health records. This study...
2.
Hunnicutt J, Fairburn-Beech J, Georgiou M, Richards A, Gregan Y, Quasny H, et al.
Lupus Sci Med
. 2022 Nov;
9(1).
PMID: 36450407
Objective: To characterise disease control and remission in patients with SLE receiving belimumab for up to 12 months in the real world. Methods: This post hoc analysis (GSK Study 213502)...
3.
Sada K, Kojo Y, Fairburn-Beech J, Sato K, Akiyama S, Van Dyke M, et al.
Mod Rheumatol
. 2021 Dec;
32(2):380-386.
PMID: 34894250
Objectives: To estimate eosinophilic granulomatosis with polyangiitis (EGPA) prevalence and disease burden in patients with newly diagnosed EGPA in Japan. Methods: This retrospective descriptive cohort study (GSK ID: 209751, HO-18-19652)...
4.
Averell C, Hinds D, Fairburn-Beech J, Wu B, Lima R
J Asthma Allergy
. 2021 Jul;
14:755-771.
PMID: 34234471
Rationale: The National Heart, Lung, and Blood Institute (NHLBI) recommend a stepwise approach to asthma management, with the goals of maintaining asthma control and reducing exacerbations. Although asthma treatments reduce...
5.
Suzuki T, Fairburn-Beech J, Sato K, Kaise T
Curr Med Res Opin
. 2020 May;
36(6):1049-1057.
PMID: 32363945
To help optimize triple therapy use, treatment patterns and disease burden were investigated in patients in Japan with persistent asthma who initiated multi-inhaler triple therapy (inhaled corticosteroid/long-acting β-agonist/long-acting muscarinic antagonist;...
6.
Gibbons D, Aggarwal B, Fairburn-Beech J, Hinds D, Fletcher M, Bosnic-Anticevich S, et al.
J Asthma
. 2020 Feb;
58(6):793-804.
PMID: 32090642
To describe patient characteristics, treatment patterns and healthcare utilization (HCU) of non-active users of maintenance asthma medications in the United Kingdom. Retrospective, cohort analysis of patients with asthma, aged ≥...
7.
Gokhale M, Bell C, Doyle S, Fairburn-Beech J, Steinfeld J, Van Dyke M
J Clin Rheumatol
. 2019 Nov;
27(3):107-113.
PMID: 31693654
Objective: To estimate the prevalence and associated disease burden of eosinophilic granulomatosis with polyangiitis (EGPA) in patients with asthma from a US claims database. Methods: Two cohorts were defined using...
8.
Alexander M, Loomis A, Fairburn-Beech J, van der Lei J, Duarte-Salles T, Prieto-Alhambra D, et al.
BMC Med
. 2018 Aug;
16(1):130.
PMID: 30099968
Background: Non-alcoholic fatty liver disease (NAFLD) is the most common cause of liver disease worldwide. It affects an estimated 20% of the general population, based on cohort studies of varying...